OCUGEN, INC. Class of Warrant or Right, Outstanding
OCUGEN, INC. (OCGN) had Class of Warrant or Right, Outstanding of 10.60 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-06
- 2026-06-30: Class of Warrant or Right, Outstanding 10.60M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 10.60M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 20.60M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 20.60M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 10.60M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 10.60M shares 10-Q · filed 2026-05-08 |
| 2025-12-31 | 20.60M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 20.60M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 600.00K shares 10-Q · filed 2025-08-04 |
| 2025-03-31 | 600.00K shares 10-Q · filed 2025-05-09 |
| 2024-12-31 | 600.00K shares 10-K · filed 2026-03-04 |
| 2024-09-30 | 600.00K shares 10-Q · filed 2024-11-14 |
| 2023-12-31 | 600.00K shares 10-K · filed 2025-03-05 |
| 2019-12-31 | 8.77M shares 10-K · filed 2020-03-27 |
| 2018-12-31 | 0.00 shares 10-K · filed 2020-03-27 |
| 2015-12-31 | 156.14K shares 10-K · filed 2016-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |